{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T19:20:42Z","timestamp":1781551242146,"version":"3.54.5"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T00:00:00Z","timestamp":1572912000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T00:00:00Z","timestamp":1572912000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lung"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s00408-019-00280-x","type":"journal-article","created":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T16:03:17Z","timestamp":1572969797000},"page":"803-810","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Management of Australian Adults with Bronchiectasis in Tertiary Care: Evidence-Based or Access-Driven?"],"prefix":"10.1007","volume":"197","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3817-0123","authenticated-orcid":false,"given":"Simone K.","family":"Visser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter T. P.","family":"Bye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg J.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy D.","family":"Burr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne B.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Li","family":"Holmes-Liew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G.","family":"Middleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme P.","family":"Maguire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel M.","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enna","family":"Stroil-Salama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warwick J.","family":"Britton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy C.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,5]]},"reference":[{"issue":"1","key":"280_CR1","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1183\/13993003.01033-2015","volume":"47","author":"JK Quint","year":"2016","unstructured":"Quint JK, Millett ERC, Joshi M, Navaratnam V, Thomas SL, Hurst JR, Smeeth L, Brown JS (2016) Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study. Eur Respir J 47(1):186\u2013193. \nhttps:\/\/doi.org\/10.1183\/13993003.01033-2015","journal-title":"Eur Respir J"},{"issue":"1421","key":"280_CR2","first-page":"30","volume":"128","author":"S Bibby","year":"2015","unstructured":"Bibby S, Milne R, Beasley R (2015) Hospital admissions for non-cystic fibrosis bronchiectasis in New Zealand. N Z Med J 128(1421):30\u201338","journal-title":"N Z Med J"},{"issue":"8","key":"280_CR3","doi-asserted-by":"publisher","first-page":"e71109","DOI":"10.1371\/journal.pone.0071109","volume":"8","author":"FC Ringshausen","year":"2013","unstructured":"Ringshausen FC, de Roux A, Pletz MW, H\u00e4m\u00e4l\u00e4inen N, Welte T, Rademacher J (2013) Bronchiectasis-associated hospitalizations in Germany, 2005\u20132011: a population-based study of disease burden and trends. PLoS ONE 8(8):e71109. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0071109","journal-title":"PLoS ONE"},{"issue":"2","key":"280_CR4","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1378\/chest.11-2209","volume":"142","author":"AE Seitz","year":"2012","unstructured":"Seitz AE, Olivier KN, Adjemian J, Holland SM, Prevots R (2012) Trends in bronchiectasis among medicare beneficiaries in the United States, 2000 to 2007. Chest 142(2):432\u2013439","journal-title":"Chest"},{"issue":"4","key":"280_CR5","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.cpm.0000171422.98696.ed","volume":"12","author":"D Weycker","year":"2005","unstructured":"Weycker D, Edelsberg J, Oster G, Tino G (2005) Prevalence and economic burden of bronchiectasis. Clin Pulm Med 12(4):205\u2013209. \nhttps:\/\/doi.org\/10.1097\/01.cpm.0000171422.98696.ed","journal-title":"Clin Pulm Med"},{"issue":"10150","key":"280_CR6","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/S0140-6736(18)31767-7","volume":"392","author":"PA Flume","year":"2018","unstructured":"Flume PA, Chalmers JD, Olivier KN (2018) Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity. Lancet 392(10150):880\u2013890. \nhttps:\/\/doi.org\/10.1016\/S0140-6736(18)31767-7","journal-title":"Lancet"},{"issue":"11","key":"280_CR7","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1111\/resp.13398","volume":"23","author":"SC Bell","year":"2018","unstructured":"Bell SC, Elborn JS, Byrnes CA (2018) Bronchiectasis: Treatment decisions for pulmonary exacerbations and their prevention: pulmonary exacerbations in bronchiectasis. Respirology 23(11):1006\u20131022. \nhttps:\/\/doi.org\/10.1111\/resp.13398","journal-title":"Respirology"},{"issue":"9","key":"280_CR8","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S2213-2600(18)30053-5","volume":"6","author":"JD Chalmers","year":"2018","unstructured":"Chalmers JD, Chotirmall SH (2018) Bronchiectasis: new therapies and new perspectives. Lancet Respir Med 6(9):715\u2013726. \nhttps:\/\/doi.org\/10.1016\/S2213-2600(18)30053-5","journal-title":"Lancet Respir Med"},{"issue":"3","key":"280_CR9","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/resp.12247","volume":"19","author":"DJ Serisier","year":"2014","unstructured":"Serisier DJ (2014) The evidence base for non-CF bronchiectasis is finally evolving. Respirology 19(3):295\u2013297. \nhttps:\/\/doi.org\/10.1111\/resp.12247","journal-title":"Respirology"},{"issue":"2 Pt 1","key":"280_CR10","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1164\/ajrccm.162.2.9910086","volume":"162","author":"AF Barker","year":"2000","unstructured":"Barker AF, Couch L, Fiel SB, Gotfried MH, Ilowite J, Meyer KC, O'Donnell A, Sahn SA, Smith LJ, Stewart JO, Abuan T, Tully H, Van Dalfsen J, Wells CD, Quan J (2000) Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis. Am J Respir Crit Care Med 162(2 Pt 1):481\u2013485. \nhttps:\/\/doi.org\/10.1164\/ajrccm.162.2.9910086","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"280_CR11","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/S2213-2600(14)70165-1","volume":"2","author":"AF Barker","year":"2014","unstructured":"Barker AF, O'Donnell AE, Flume P, Thompson PJ, Ruzi JD, de Gracia J, Boersma WG, De Soyza A, Shao L, Zhang J, Haas L, Lewis SA, Leitzinger S, Montgomery AB, McKevitt MT, Gossage D, Quittner AL, O'Riordan TG (2014) Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials. Lancet Respir Med 2(9):738\u2013749. \nhttps:\/\/doi.org\/10.1016\/S2213-2600(14)70165-1","journal-title":"Lancet Respir Med"},{"issue":"5","key":"280_CR12","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1378\/chest.113.5.1329","volume":"113","author":"AE O'Donnell","year":"1998","unstructured":"O'Donnell AE, Barker AF, Ilowite JS, Fick RB (1998) Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. Chest 113(5):1329\u20131334. \nhttps:\/\/doi.org\/10.1378\/chest.113.5.1329","journal-title":"Chest"},{"issue":"12","key":"280_CR13","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1001\/jama.2013.1937","volume":"309","author":"J Altenburg","year":"2013","unstructured":"Altenburg J, de Graaff CS, Stienstra Y, Sloos JH, van Haren EHJ, Koppers RJH, van der Werf TS, Boersma WG (2013) Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial. JAMA 309(12):1251\u20131259. \nhttps:\/\/doi.org\/10.1001\/jama.2013.1937","journal-title":"JAMA"},{"issue":"12","key":"280_CR14","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1001\/jama.2013.2290","volume":"309","author":"DJ Serisier","year":"2013","unstructured":"Serisier DJ, Martin ML, McGuckin MA, Lourie R, Chen AC, Brain B, Biga S, Schlebusch S, Dash P, Bowler SD (2013) Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial. JAMA 309(12):1260\u20131267. \nhttps:\/\/doi.org\/10.1001\/jama.2013.2290","journal-title":"JAMA"},{"issue":"9842","key":"280_CR15","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/S0140-6736(12)60953-2","volume":"380","author":"C Wong","year":"2012","unstructured":"Wong C, Jayaram L, Karalus N, Eaton T, Tong C, Hockey H, Milne D, Fergusson W, Tuffery C, Sexton P, Storey L, Ashton T (2012) Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial. Lancet 380(9842):660\u2013667. \nhttps:\/\/doi.org\/10.1016\/S0140-6736(12)60953-2","journal-title":"Lancet"},{"issue":"3","key":"280_CR16","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/resp.12233","volume":"19","author":"Q Wu","year":"2014","unstructured":"Wu Q, Shen W, Cheng H, Zhou X (2014) Long-term macrolides for non-cystic fibrosis bronchiectasis: a systematic review and meta-analysis. Respirology 19(3):321\u2013329. \nhttps:\/\/doi.org\/10.1111\/resp.12233","journal-title":"Respirology"},{"issue":"1","key":"280_CR17","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.pupt.2014.02.002","volume":"29","author":"G-Y Zhuo","year":"2014","unstructured":"Zhuo G-Y, He Q, Xiang-Lian L, Ya-Nan Y, Si-Te F (2014) Prolonged treatment with macrolides in adult patients with non-cystic fibrosis bronchiectasis: meta-analysis of randomized controlled trials. Pulm Pharmacol Ther 29(1):80\u201388. \nhttps:\/\/doi.org\/10.1016\/j.pupt.2014.02.002","journal-title":"Pulm Pharmacol Ther"},{"issue":"1","key":"280_CR18","doi-asserted-by":"publisher","first-page":"1702053","DOI":"10.1183\/13993003.02053-2017","volume":"51","author":"T Aksamit","year":"2018","unstructured":"Aksamit T, De Soyza A, Bandel TJ, Criollo M, Elborn JS, Operschall E, Polverino E, Roth K, Winthrop KL, Wilson R (2018) RESPIRE 2: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis. Eur Respir J 51(1):1702053. \nhttps:\/\/doi.org\/10.1183\/13993003.02053-2017","journal-title":"Eur Respir J"},{"issue":"1","key":"280_CR19","doi-asserted-by":"publisher","first-page":"1702052","DOI":"10.1183\/13993003.02052-2017","volume":"51","author":"A De Soyza","year":"2018","unstructured":"De Soyza A, Aksamit T, Bandel T-J, Criollo M, Elborn JS, Operschall E, Polverino E, Roth K, Winthrop KL, Wilson R (2018) RESPIRE 1: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis. Eur Respir J 51(1):1702052","journal-title":"Eur Respir J"},{"key":"280_CR20","doi-asserted-by":"crossref","unstructured":"Haworth CS, Bilton D, Chalmers JD, Davis AM, Froehlich J, Gonda I, Thompson B, Wanner A, O'Donnell AE (2019) Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials. Lancet Respir Med","DOI":"10.1016\/S2213-2600(18)30427-2"},{"issue":"8","key":"280_CR21","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1164\/rccm.201312-2208OC","volume":"189","author":"CS Haworth","year":"2014","unstructured":"Haworth CS, Foweraker JE, Wilkinson P, Kenyon RF, Bilton D (2014) Inhaled colistin in patients with bronchiectasis and chronic pseudomonas aeruginosa infection. Am J Respir Crit Care Med 189(8):975\u2013982. \nhttps:\/\/doi.org\/10.1164\/rccm.201312-2208OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"280_CR22","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1136\/thoraxjnl-2014-205587","volume":"69","author":"D Bilton","year":"2014","unstructured":"Bilton D, Tino G, Barker AF, Chambers DC, De Soyza A, Dupont LJA, O'Dochartaigh C, van Haren EHJ, Vidal LO, Welte T, Fox HG, Wu J, Charlton B, Investigators BS (2014) Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial. Thorax 69(12):1073\u20131079. \nhttps:\/\/doi.org\/10.1136\/thoraxjnl-2014-205587","journal-title":"Thorax"},{"issue":"1","key":"280_CR23","doi-asserted-by":"publisher","first-page":"21","DOI":"10.5694\/mja14.00287","volume":"202","author":"AB Chang","year":"2015","unstructured":"Chang AB, Bell SC, Torzillo PJ, King PT, Maguire GP, Byrnes CA, Holland AE, O\u2019Mara P, Grimwood K, Alison J, Cull C, Currie B, Gardner I, Holmes P, Hunter C, Kolbe J, Maclennan C, McDonald M, Morris P, Nicolson C, Petsky H, Pillarisetti N, Reynolds E, Serisier D, Thein F, van Asperen P, Voss L, Wong C (2015) Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand. Med J Aust 202(1):21\u201324. \nhttps:\/\/doi.org\/10.5694\/mja14.00287","journal-title":"Med J Aust"},{"issue":"2","key":"280_CR24","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.arbr.2017.07.014","volume":"54","author":"M\u00c1 Mart\u00ednez-Garc\u00eda","year":"2018","unstructured":"Mart\u00ednez-Garc\u00eda M\u00c1, M\u00e1iz L, Olveira C, Gir\u00f3n RM, de la Rosa D, Blanco M, Cant\u00f3n R, Vendrell M, Polverino E, de Gracia J (2018) Spanish guidelines on treatment of bronchiectasis in adults. Arch Bronconeumol (Engl Edn) 54(2):88\u201398","journal-title":"Arch Bronconeumol (Engl Edn)"},{"issue":"Suppl 1","key":"280_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/thoraxjnl-2018-212463","volume":"74","author":"AT Hill","year":"2019","unstructured":"Hill AT, Sullivan AL, Chalmers JD, De Soyza A, Elborn JS, Floto RA, Grillo L, Gruffydd-Jones K, Harvey A, Haworth CS (2019) British Thoracic Society guideline for bronchiectasis in adults. Thorax 74(Suppl 1):1\u201369","journal-title":"Thorax"},{"issue":"3","key":"280_CR26","doi-asserted-by":"publisher","first-page":"1700629","DOI":"10.1183\/13993003.00629-2017","volume":"50","author":"E Polverino","year":"2017","unstructured":"Polverino E, Goeminne PC, McDonnell MJ, Aliberti S, Marshall SE, Loebinger MR, Murris M, Cant\u00f3n R, Torres A, Dimakou K (2017) European Respiratory Society guidelines for the management of adult bronchiectasis. Eur Respir J 50(3):1700629","journal-title":"Eur Respir J"},{"issue":"5","key":"280_CR27","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1164\/rccm.201309-1575OC","volume":"189","author":"JD Chalmers","year":"2014","unstructured":"Chalmers JD, Goeminne P, Aliberti S, McDonnell MJ, Lonni S, Davidson J, Poppelwell L, Salih W, Pesci A, Dupont LJ, Fardon TC, De Soyza A, Hill AT (2014) The bronchiectasis severity index an international derivation and validation study. Am J Respir Crit Care Med 189(5):576\u2013585. \nhttps:\/\/doi.org\/10.1164\/rccm.201309-1575OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"280_CR28","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.apmr.2016.05.017","volume":"98","author":"AL Lee","year":"2017","unstructured":"Lee AL, Hill CJ, McDonald CF, Holland AE (2017) Pulmonary rehabilitation in individuals with non-cystic fibrosis bronchiectasis: a systematic review. Arch Phys Med Rehab 98(4):774\u2013782","journal-title":"Arch Phys Med Rehab"},{"issue":"12","key":"280_CR29","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1016\/j.rmed.2012.08.004","volume":"106","author":"P Mandal","year":"2012","unstructured":"Mandal P, Sidhu M, Kope L, Pollock W, Stevenson L, Pentland J, Turnbull K, Mac Quarrie S, Hill A (2012) A pilot study of pulmonary rehabilitation and chest physiotherapy versus chest physiotherapy alone in bronchiectasis. Respir Med 106(12):1647\u20131654","journal-title":"Respir Med"},{"issue":"1","key":"280_CR30","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1465-9921-15-44","volume":"15","author":"AL Lee","year":"2014","unstructured":"Lee AL, Hill CJ, Cecins N, Jenkins S, McDonald CF, Burge AT, Rautela L, Stirling RG, Thompson PJ, Holland AE (2014) The short and long term effects of exercise training in non-cystic fibrosis bronchiectasis\u2014a randomised controlled trial. Respir Res 15(1):44","journal-title":"Respir Res"},{"issue":"1","key":"280_CR31","doi-asserted-by":"publisher","first-page":"1801264","DOI":"10.1183\/13993003.01264-2018","volume":"53","author":"S Patel","year":"2019","unstructured":"Patel S, Cole AD, Nolan CM, Barker RE, Jones SE, Kon S, Cairn J, Loebinger M, Wilson R, Man WD (2019) Pulmonary rehabilitation in bronchiectasis: a propensity-matched study. Eur Respir J 53(1):1801264","journal-title":"Eur Respir J"},{"key":"280_CR32","doi-asserted-by":"crossref","unstructured":"Walker P, Herrero B, Spinou A, Dimakou K, Blasi F, Ringshausen F, De Soyza A, Vendrell M, Goeminne P, Boersma W (2018) Variability in access and referral to pulmonary rehabilitation in European bronchiectasis patients enrolled in the EMBARC registry. Eur Respiratory Soc.","DOI":"10.1183\/13993003.congress-2018.OA5201"},{"key":"280_CR33","doi-asserted-by":"crossref","unstructured":"Lee AL, Burge AT, Holland AE (2015) Airway clearance techniques for bronchiectasis. Cochrane Database Syst Rev 11:CD008351","DOI":"10.1002\/14651858.CD008351.pub3"},{"issue":"11","key":"280_CR34","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1513\/AnnalsATS.201506-333OC","volume":"12","author":"S Finch","year":"2015","unstructured":"Finch S, McDonnell MJ, Abo-Leyah H, Aliberti S, Chalmers JD (2015) A comprehensive analysis of the impact of pseudomonas aeruginosa colonization on prognosis in adult bronchiectasis. Ann Am Thorac Soc 12(11):1602\u20131611. \nhttps:\/\/doi.org\/10.1513\/AnnalsATS.201506-333OC","journal-title":"Ann Am Thorac Soc"},{"issue":"2","key":"280_CR35","doi-asserted-by":"publisher","first-page":"1701953","DOI":"10.1183\/13993003.01953-2017","volume":"51","author":"D Ara\u00fajo","year":"2018","unstructured":"Ara\u00fajo D, Shteinberg M, Aliberti S, Goeminne PC, Hill AT, Fardon TC, Obradovic D, Stone G, Trautmann M, Davis A (2018) The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis. Eur Respir J 51(2):1701953","journal-title":"Eur Respir J"},{"issue":"6","key":"280_CR36","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1111\/crj.12278","volume":"10","author":"JW Yang","year":"2016","unstructured":"Yang JW, Fan LC, Lu HW, Miao XY, Mao B, Xu JF (2016) Efficacy and safety of long-term inhaled antibiotic for patients with noncystic fibrosis bronchiectasis: a meta-analysis. Clin Respir J 10(6):731\u2013739. \nhttps:\/\/doi.org\/10.1111\/crj.12278","journal-title":"Clin Respir J"},{"issue":"2","key":"280_CR37","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1183\/09031936.00018414","volume":"44","author":"AM Brodt","year":"2014","unstructured":"Brodt AM, Stovold E, Zhang L (2014) Inhaled antibiotics for stable non-cystic fibrosis bronchiectasis: a systematic review. Eur Respir J 44(2):382\u2013393","journal-title":"Eur Respir J"},{"issue":"9","key":"280_CR38","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1691\/ph.2016.6590","volume":"71","author":"L Xu","year":"2016","unstructured":"Xu L, Zhang F, Du S, Yu Q, Chen L, Long LH, Li YM, Jia AH (2016) Inhaled antibiotics in non-cystic fibrosis bronchiectasis: a meta-analysis. Pharmazie 71(9):491\u2013498. \nhttps:\/\/doi.org\/10.1691\/ph.2016.6590","journal-title":"Pharmazie"},{"issue":"7","key":"280_CR39","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1164\/rccm.201203-0487OC","volume":"186","author":"JD Chalmers","year":"2012","unstructured":"Chalmers JD, Smith MP, McHugh BJ, Doherty C, Govan JR, Hill AT (2012) Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med 186(7):657\u2013665. \nhttps:\/\/doi.org\/10.1164\/rccm.201203-0487OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"280_CR40","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1164\/rccm.201312-2208OC","volume":"189","author":"CS Haworth","year":"2014","unstructured":"Haworth CS, Foweraker JE, Wilkinson P, Kenyon RF, Bilton D (2014) Inhaled colistin in patients with bronchiectasis and chronic Pseudomonas aeruginosa infection. Am J Respir Crit Care Med 189(8):975","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"280_CR41","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1164\/rccm.201711-2202OC","volume":"197","author":"JD Chalmers","year":"2018","unstructured":"Chalmers JD, Aliberti S, Filonenko A, Shteinberg M, Goeminne PC, Hill AT, Fardon TC, Obradovic D, Gerlinger C, Sotgiu G, Operschall E, Rutherford RM, Dimakou K, Polverino E, De Soyza A, McDonnell MJ (2018) Characterization of the \"frequent exacerbator phenotype\" in Bronchiectasis. Am J Respir Crit Care Med 197(11):1410\u20131420. \nhttps:\/\/doi.org\/10.1164\/rccm.201711-2202OC","journal-title":"Am J Respir Crit Care Med"},{"key":"280_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/thoraxjnl-2017-210927","volume":"72","author":"CS Haworth","year":"2017","unstructured":"Haworth CS, Banks J, Capstick T, Fisher AJ, Gorsuch T, Laurenson IF, Leitch A, Loebinger MR, Milburn HJ, Nightingale M, Ormerod P, Shingadia D, Smith D, Whitehead N, Wilson R, Floto RA (2017) British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD). Thorax 72:1\u201364. \nhttps:\/\/doi.org\/10.1136\/thoraxjnl-2017-210927","journal-title":"Thorax"},{"issue":"10","key":"280_CR43","doi-asserted-by":"publisher","first-page":"436","DOI":"10.5694\/mja17.00686","volume":"207","author":"IA Yang","year":"2017","unstructured":"Yang IA, Brown JL, George J, Jenkins S, McDonald CF, McDonald VM, Phillips K, Smith BJ, Zwar NA, Dabscheck E (2017) COPD-X Australian and New Zealand guidelines for the diagnosis and management of chronic obstructive pulmonary disease: 2017 update. Med J Aust 207(10):436\u2013442","journal-title":"Med J Aust"},{"key":"280_CR44","doi-asserted-by":"crossref","unstructured":"Kapur N, Petsky HL, Bell S, Kolbe J, Chang AB (2018) Inhaled corticosteroids for bronchiectasis. Cochrane Database Syst Rev 5:CD000996","DOI":"10.1002\/14651858.CD000996.pub3"},{"issue":"3","key":"280_CR45","doi-asserted-by":"publisher","first-page":"1800328","DOI":"10.1183\/13993003.00328-2018","volume":"52","author":"E Polverino","year":"2018","unstructured":"Polverino E, Dimakou K, Hurst J, Martinez-Garcia M-A, Miravitlles M, Paggiaro P, Shteinberg M, Aliberti S, Chalmers JD (2018) The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions. Eur Respir J 52(3):1800328. \nhttps:\/\/doi.org\/10.1183\/13993003.00328-2018","journal-title":"Eur Respir J"},{"issue":"10","key":"280_CR46","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1513\/AnnalsATS.201804-245OC","volume":"15","author":"VX Liu","year":"2018","unstructured":"Liu VX, Winthrop KL, Lu Y, Sharifi H, Nasiri HU, Ruoss SJ (2018) Association between Inhaled corticosteroid use and pulmonary nontuberculous mycobacterial infection. Ann Am Thorac Soc 15(10):1169\u20131176","journal-title":"Ann Am Thorac Soc"},{"key":"280_CR47","unstructured":"Global Initiative for Asthma (2017) Global strategy for asthma management and prevention."}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-019-00280-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00408-019-00280-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-019-00280-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T00:27:21Z","timestamp":1604449641000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00408-019-00280-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,5]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["280"],"URL":"https:\/\/doi.org\/10.1007\/s00408-019-00280-x","relation":{},"ISSN":["0341-2040","1432-1750"],"issn-type":[{"value":"0341-2040","type":"print"},{"value":"1432-1750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,5]]},"assertion":[{"value":"8 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}